WallStreetZenWallStreetZen

NYSE: USNA
Usana Health Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their USNA stock forecasts and price targets.

Forecast return on equity

Is USNA forecast to generate an efficient return?

Company
6.34%
Industry
12.94%
Market
131.97%
USNA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is USNA forecast to generate an efficient return on assets?

Company
4.74%
Industry
5.64%
USNA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

USNA earnings per share forecast

What is USNA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.78
Avg 2 year Forecast
$1.81

USNA revenue forecast

What is USNA's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$927.8M+1.58%
Avg 2 year Forecast
$968.8M+6.07%
USNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

USNA revenue growth forecast

How is USNA forecast to perform vs Packaged Foods companies and vs the US market?

Company
1.58%
Industry
1.54%
Market
19.9%
USNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
USNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

USNA vs Food Stocks

TickerPricePrice TargetUp/downsideConsensus
USNA$14.04N/AN/A
BGS$2.98$4.25+42.62%Sell
UCFI$5.51N/AN/A
NATR$12.95$31.33+141.95%Strong Buy
BRCC$8.97$25.00+178.71%Strong Buy
View Top Food Stocks

Usana Health Sciences Stock Forecast FAQ

What is USNA's earnings growth forecast for 2026-2027?

(NYSE: USNA) Usana Health Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Packaged Foods industry's average forecast earnings growth rate of 50.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,178.03%.

Usana Health Sciences's earnings in 2026 is -$22,164,000.On average, 3 Wall Street analysts forecast USNA's earnings for 2026 to be $14,323,009, with the lowest USNA earnings forecast at $13,761,323, and the highest USNA earnings forecast at $14,744,274.

In 2027, USNA is forecast to generate $33,357,534 in earnings, with the lowest earnings forecast at $32,049,396 and the highest earnings forecast at $34,338,638.

If you're new to stock investing, here's how to buy Usana Health Sciences stock.

What is USNA's revenue growth forecast for 2026-2027?

(NYSE: USNA) Usana Health Sciences's forecast annual revenue growth rate of 1.58% is forecast to beat the US Packaged Foods industry's average forecast revenue growth rate of 1.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.9%.

Usana Health Sciences's revenue in 2026 is $913,361,000.On average, 3 Wall Street analysts forecast USNA's revenue for 2026 to be $17,141,789,184, with the lowest USNA revenue forecast at $16,469,612,877, and the highest USNA revenue forecast at $17,646,013,797.

In 2027, USNA is forecast to generate $17,900,805,201 in revenue, with the lowest revenue forecast at $17,198,696,909 and the highest revenue forecast at $18,427,201,654.

What is USNA's forecast return on assets (ROA) for 2026-2027?

(NYSE: USNA) forecast ROA is 4.74%, which is lower than the forecast US Packaged Foods industry average of 5.64%.

What is USNA's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: USNA) Usana Health Sciences's current Earnings Per Share (EPS) is -$1.20. On average, analysts forecast that USNA's EPS will be $0.78 for 2026, with the lowest EPS forecast at $0.74, and the highest EPS forecast at $0.80. In 2027, USNA's EPS is forecast to hit $1.81 (min: $1.73, max: $1.86).

What is USNA's forecast return on equity (ROE) for 2026-2027?

(NYSE: USNA) forecast ROE is 6.34%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.